FI974640A - Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit - Google Patents

Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit Download PDF

Info

Publication number
FI974640A
FI974640A FI974640A FI974640A FI974640A FI 974640 A FI974640 A FI 974640A FI 974640 A FI974640 A FI 974640A FI 974640 A FI974640 A FI 974640A FI 974640 A FI974640 A FI 974640A
Authority
FI
Finland
Prior art keywords
isochromanes
migraine
disubstituted
treatment
disubstituted isochromanes
Prior art date
Application number
FI974640A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI974640A0 (fi
Inventor
Michael D Ennis
Ruth E Tenbrink
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI974640A0 publication Critical patent/FI974640A0/fi
Publication of FI974640A publication Critical patent/FI974640A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI974640A 1995-06-30 1997-12-30 Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit FI974640A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US1123496P 1996-02-06 1996-02-06
PCT/US1996/008681 WO1997002259A1 (en) 1995-06-30 1996-06-07 1,6-disubstituted isochromans for treatment of migraine headaches

Publications (2)

Publication Number Publication Date
FI974640A0 FI974640A0 (fi) 1997-12-30
FI974640A true FI974640A (fi) 1997-12-30

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
FI974640A FI974640A (fi) 1995-06-30 1997-12-30 Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit

Country Status (12)

Country Link
EP (1) EP0836599A1 (ja)
JP (1) JPH11509532A (ja)
AU (1) AU6252296A (ja)
BR (1) BR9609631A (ja)
CA (1) CA2225282A1 (ja)
CZ (1) CZ418597A3 (ja)
FI (1) FI974640A (ja)
MX (1) MX9710260A (ja)
NO (1) NO976112L (ja)
PL (1) PL324319A1 (ja)
SK (1) SK164297A3 (ja)
WO (1) WO1997002259A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
KR100823805B1 (ko) 2004-05-05 2008-04-21 에프. 호프만-라 로슈 아게 5-ht6 수용체, 5-ht2a 수용체 또는 둘다를 조절하기에유용한 아릴설포닐 벤조다이옥산
CN101111472A (zh) 2004-12-21 2008-01-23 弗·哈夫曼-拉罗切有限公司 1,2,3,4-四氢化萘和茚满衍生物及其作为5-ht拮抗剂的用途
DK1831159T3 (da) 2004-12-21 2010-03-22 Hoffmann La Roche Tetralin og indanderivater samt anvendelser deraf
KR100965190B1 (ko) 2004-12-21 2010-06-24 에프. 호프만-라 로슈 아게 크로만 유도체 및 중추 신경계 장애의 치료에서 그의 용도
WO2006066745A1 (en) 2004-12-21 2006-06-29 F.Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
KR20070088798A (ko) 2004-12-21 2007-08-29 에프. 호프만-라 로슈 아게 크로만 유도체 및 그의 5-ht 수용체 리간드로서의 용도
BRPI0618206A2 (pt) 2005-11-03 2011-08-23 Hoffmann La Roche arilsulfonil cromanos como inibidores de 5-ht6, bem como composição farmacêutica, uso e processo para produção dos mesmos
AU2007263084A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
EP2076489A1 (en) 2006-06-20 2009-07-08 F. Hoffmann-Roche AG Arylsulfonamidyl tetralin derivatives and uses thereof
CA2654822A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Arylsulfonyl naphthalene derivatives and uses thereof
KR20110125258A (ko) * 2009-03-05 2011-11-18 스미또모 가가꾸 가부시끼가이샤 할로겐 치환 벤젠디메탄올의 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
AU684874B2 (en) * 1993-12-28 1998-01-08 Pharmacia & Upjohn Company Heterocyclic compounds for the treatment of cns and cardiovascular disorders

Also Published As

Publication number Publication date
SK164297A3 (en) 1998-09-09
FI974640A0 (fi) 1997-12-30
NO976112L (no) 1998-03-02
CZ418597A3 (cs) 1998-06-17
MX9710260A (es) 1998-03-29
NO976112D0 (no) 1997-12-29
JPH11509532A (ja) 1999-08-24
AU6252296A (en) 1997-02-05
EP0836599A1 (en) 1998-04-22
WO1997002259A1 (en) 1997-01-23
BR9609631A (pt) 1999-03-02
CA2225282A1 (en) 1997-01-23
PL324319A1 (en) 1998-05-25

Similar Documents

Publication Publication Date Title
NO981800D0 (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO961483D0 (no) Fremgangsmåte for behandling av oljeholdig formasjon
FI974640A (fi) Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
ITTO940748A0 (it) Condotto protesico particolarmente per il trattamento di patologie cardiovascolari.
HUP0004085A3 (en) Novel 3,6-hemiketals from the class of 9a-azalides
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
ITTO960495A0 (it) Procedimento per accrescere il flusso per elettrotrasporto di polipep-tidi.
DE69618634D1 (de) 1,4-benzodioxin-derivate
IT1292552B1 (it) Dispositivo per l'applicazione di rivestimenti.
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
NO985535D0 (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
HK1010095A1 (en) Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
DK0783491T3 (da) Fremgangsmåde til fremstilling af 3,3,5-trichlorglutarimid
ES1031096Y (es) Ducha antivandalica.
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
FI940088A0 (fi) Regleranordning/reglerdel foer spolvattenmnaengden i en vattenklosett
DK0737068T3 (da) 2,3-diaryl-1-benzopyraner til behandling af dermatitis
RU95117268A (ru) Средство для лечения атопического дерматита
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
FI953860A0 (fi) Yhdistelmäpalkki
ITRM940468A0 (it) "impiego di esteruretani per ls riconcia".
ITTV940061A0 (it) "pedana, particolarmente per la pratica della scherma".
FI954263A0 (fi) Vid skjutning anvaendbart foerfarande foer bestaemning av traeffar